{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:25:41Z","timestamp":1788017141625,"version":"build-2784847793"},"reference-count":225,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.pharmthera.2008.05.010","type":"journal-article","created":{"date-parts":[[2008,6,21]],"date-time":"2008-06-21T08:21:20Z","timestamp":1214036480000},"page":"311-325","source":"Crossref","is-referenced-by-count":80,"title":["Angiotensin II: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks"],"prefix":"10.1016","volume":"119","author":[{"given":"K.-D.","family":"Schl\u00fcter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2008.05.010_bib1","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1074\/jbc.M510775200","article-title":"Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1","volume":"281","author":"Abbasi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib2","doi-asserted-by":"crossref","first-page":"36737","DOI":"10.1074\/jbc.M506493200","article-title":"The essential role of MEKK3 signalling in angiotensin II-induced calcineurin\/nuclear factor of activated T-cells activation","volume":"280","author":"Abbasi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib3","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1074\/jbc.M105253200","article-title":"The angiotensin II AT2 receptor is an AT1 receptor antagonist","volume":"276","author":"Abdalla","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib4","doi-asserted-by":"crossref","first-page":"H806","DOI":"10.1152\/ajpheart.1990.258.3.H806","article-title":"[Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells","volume":"258","author":"Aceto","year":"1990","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib5","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.yexcr.2007.01.009","article-title":"Re-expression of proteins involved in cytokines during cardiac hypertrophy","volume":"313","author":"Ahuja","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/01.HYP.0000128532.28165.77","article-title":"Left ventricle mass index and the common, functional, X-linked angiotensin II type-2 receptor gene polymorphism (\u22121332 G\/A) in patients with systemic hypertension","volume":"43","author":"Alfakih","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00004872-200502000-00021","article-title":"Effect of insulin and angiotensin II receptor subtype-1 antagonist on myocardial remodelling in rats with insulin-dependent diabetes mellitus","volume":"23","author":"Al-Jaroudi","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11010-005-3672-1","article-title":"Interactions between atrial natriuretic peptide and the renin\u2013angiotensin system during salt-sensitive exhibited by the proANP gene-disrupted mouse","volume":"276","author":"Angelis","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.RES.69.2.266","article-title":"Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins","volume":"69","author":"Arai","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCULATIONAHA.105.560771","article-title":"Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice","volume":"113","author":"Arimoto","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1525-1594.2007.00375.x","article-title":"Adenoviral expression of calmodulin antisense reduces hypertrophy in cultured cardiomyocytes","volume":"31","author":"Arruda","year":"2007","journal-title":"Artif Organs"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1291\/hypres.28.79","article-title":"Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and\/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction","volume":"28","author":"Asai","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm0102-35","article-title":"Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloprotease inhibitors as a new therapy","volume":"8","author":"Asakura","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.pharmthera.2008.05.010_bib14","doi-asserted-by":"crossref","first-page":"H610","DOI":"10.1152\/ajpheart.1990.259.2.H610","article-title":"Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells","volume":"259","author":"Baker","year":"1990","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.regpep.2004.04.004","article-title":"Evidence for a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy","volume":"120","author":"Baker","year":"2004","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1380.007","article-title":"Dynamic interactions between myocytes, fibroblasts, and extracellular matrix","volume":"1080","author":"Banerjee","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.CIR.99.1.22","article-title":"Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts","volume":"99","author":"Bartunek","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.2002.027573","article-title":"Streptomycin and intracellular calcium modulate the response of single guinea-pig ventricular myocytes to axial stretch","volume":"546","author":"Belus","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib19","first-page":"H2337","article-title":"Angiotensin receptors: Signalling, vascular pathophysiology, and interactions with ceramide","volume":"281","author":"Berry","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib20","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.peptides.2005.03.051","article-title":"Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT1 and AT2 receptors","volume":"26","author":"Bkaily","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/01.HYP.0000156878.17006.02","article-title":"Putting the brakes on cardiac hypertrophy: Exploiting the NO-Cgmp counter-regulatory system","volume":"45","author":"Booz","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib22","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1210\/en.130.6.3641","article-title":"Angiotensin II-binding sites on hepatocyte nuclei","volume":"130","author":"Booz","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00395-003-0387-x","article-title":"Angiotensin II effects on STAT3 phosphorylation in cardiomyocytes: Evidence for ERK-dependent Tyr705 dephosphorylation","volume":"98","author":"Booz","year":"2003","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib24","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.HYP.0000100445.80029.8E","article-title":"Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice","volume":"42","author":"Brede","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.CIR.0000156458.80515.F7","article-title":"Targeted proteolysis sustains calcineurin activation","volume":"111","author":"Burkhard","year":"2005","journal-title":"Ciruclation"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1210\/en.2004-0466","article-title":"Suppressor of cytokine signalling-3 provides a novel interface in the cross-talk between angiotensin II and insulin signalling systems","volume":"146","author":"Calegari","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1113\/jphysiol.2007.134080","article-title":"Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism","volume":"583","author":"Carneiro-Ramos","year":"2007","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib29","doi-asserted-by":"crossref","first-page":"H1635","DOI":"10.1152\/ajpheart.00612.2005","article-title":"Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy","volume":"290","author":"Christoffersen","year":"2006","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib226","first-page":"F299","article-title":"Targeting deletion of angiotensin type 1B receptor gene in the mouse","volume":"272","author":"Chen","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.HYP.0000208302.62399.68","article-title":"The positive inotropic effect of angiotensin II: Role of endothelin-1 and reactive oxygen species","volume":"47","author":"Cingolani","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib31","first-page":"H573","article-title":"Cultured adult cardiac myocytes maintain protein synthesis capacity of intact adult hearts","volume":"264","author":"Clark","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib32","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.yjmcc.2005.11.014","article-title":"Nuclear accumulation of the AT1 receptor in a rat vascular smooth muscle cell line: Effects upon signal transduction and cellular proliferation","volume":"40","author":"Cook","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib33","doi-asserted-by":"crossref","first-page":"C1313","DOI":"10.1152\/ajpcell.00454.2006","article-title":"Cleavage of the angiotensin AT1 receptor and nuclear accumulation of the cytoplasmatic carboxy-terminal fragment","volume":"292","author":"Cook","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib34","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cardiores.2006.04.005","article-title":"Association of RhoGDI\u03b1 with Rac1 GTPase mediates free radical production during myocardial hypertrophy","volume":"71","author":"Custodis","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib35","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/01.HYP.0000193504.51489.cf","article-title":"The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy","volume":"46","author":"D'Amore","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib36","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/01.HYP.32.6.976","article-title":"Intracellular angiotensin II regulates the inward calcium current in cardiac myocytes","volume":"32","author":"De Mello","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib37","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/HYPERTENSIONAHA.107.100693","article-title":"Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology","volume":"51","author":"Der Sarkissian","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00424-006-0192-0","article-title":"Angiotensin type (AT1) and type 2 (AT2) receptors mediate the increase in TGF-b1 in thyroid hormone-induced cardiac hypertrophy","volume":"454","author":"Diniz","year":"2007","journal-title":"Pflugers Arch \u2013 Eur J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib39","doi-asserted-by":"crossref","first-page":"C838","DOI":"10.1152\/ajpcell.1992.263.4.C838","article-title":"Intracardiac detection of angiotensinogen and renin: A localized renin\u2013angiotensin system in neonatal rat heart","volume":"263","author":"Dostal","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib40","first-page":"F776","article-title":"Rabbit renal epithelial angiotensin II receptor nomenclature","volume":"267","author":"Dulin","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.HYP.28.5.818","article-title":"Subcellular localization of angiotensin II immunoreactivity in the rat cerebellar cortex","volume":"28","author":"Erdmann","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib42","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/HJH.0b013e328121aae7","article-title":"Dose and time-dependent apoptotic effects by angiotensin II infusion on left ventricular cardiomyocytes","volume":"25","author":"Fabris","year":"2007","journal-title":"J Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib43","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1161\/CIRCULATIONAHA.104.521625","article-title":"Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage","volume":"111","author":"Fiebeler","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cardiores.2004.04.002","article-title":"Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes","volume":"63","author":"Fiedler","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jcp.20307","article-title":"Role of interleukin-6 in cardiomyocyte\/cardiac fibroblast interaction during myocyte hypertrophy and fibroblast proliferation","volume":"204","author":"Fredj","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib46","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","article-title":"Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo","volume":"111","author":"Freund","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib47","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.87.12.1123","article-title":"Myocardial cell death in human diabetes","volume":"87","author":"Frustaci","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0008-6363(98)00010-8","article-title":"Enhanced expression of heparin-binding EGF-like growth factor and its receptor in hypertrophied left ventricle of spontaneously hypertensive rats","volume":"38","author":"Fujino","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib49","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1042\/bj2660727","article-title":"Effects of catecholamines on protein synthesis in cardiac myocytes and perfused hearts isolated from rats. Stimulation of translation is mediated by the \u03b11-adrenoceptor","volume":"266","author":"Fuller","year":"1990","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib50","first-page":"340","article-title":"Failure of propanolol to prevent chronic hyperthyroid induced cardiac hypertrophy and multifocal cellular necrosis in the rat","volume":"1","author":"Gerdes","year":"1987","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib51","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/01.RES.78.6.954","article-title":"Depletion of mitogen-activated protein kinase using an antisense approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes","volume":"78","author":"Glennon","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib52","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/00004872-200109000-00022","article-title":"Angiotensin II-induced apoptosis in rat cardiomyocyte culture: A possible role of AT1 and AT2 receptors","volume":"19","author":"Goldenberg","year":"2001","journal-title":"J Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib53","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0898-6568(97)00008-9","article-title":"Angiotensin II-induced inositol phosphate generation is mediated through tyrosine kinase pathways in cardiomyocytes","volume":"9","author":"Goutsouliak","year":"1997","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib54","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0306-3623(97)00270-X","article-title":"Comparison of angiotensin II type-1 and type-2 receptor antagonists on angiotensin II-induced IP3 generation in cardiomyocytes","volume":"30","author":"Goutsouliak","year":"1998","journal-title":"Gen. Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib55","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jacc.2005.09.051","article-title":"Involvement of the nucleotide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload","volume":"47","author":"Grieve","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/CS20070160","article-title":"ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts","volume":"113","author":"Grobe","year":"2007","journal-title":"Clin Sci"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib57","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00004872-200405000-00023","article-title":"Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice","volume":"22","author":"Gross","year":"2004","journal-title":"J Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-201X.2004.01322.x","article-title":"Insights into angiotensin II receptor function through AT2 receptor knockout mice","volume":"184","author":"Gross","year":"2004","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib59","first-page":"764","article-title":"Effect of age on endothelin-1 binding sites in rat cardiac ventricular membranes","volume":"19","author":"Gu","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib60","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cardiores.2005.04.015","article-title":"Functional evidence that in the cardiovascular system AT1 angiotensin II receptors are AT1B prejunctionally and AT1A postjunctionally","volume":"67","author":"Guimaraes","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib61","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.yjmcc.2004.12.015","article-title":"IL-1\u03b2 and TNF-\u03b1 upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart","volume":"38","author":"Gurantz","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib62","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/01.RES.0000243208.59795.d8","article-title":"Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy","volume":"99","author":"Hallhuber","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib63","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1152\/ajpheart.1998.274.3.H868","article-title":"Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors","volume":"274","author":"Hamawaki","year":"1998","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib64","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02190548","article-title":"Adrenergic agents, but not triiodo-L-thyroidine induce c-fos and c-myc expression in the rat heart","volume":"86","author":"Hannan","year":"1991","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib65","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.RES.82.7.779","article-title":"Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice","volume":"82","author":"Harada","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.HYP.0000198425.21604.aa","article-title":"Activation of AMP -activated protein kinase enhances angiotensin II-induced proliferation in cardiac fibroblasts","volume":"47","author":"Hattori","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib67","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.yjmcc.2006.10.017","article-title":"PKC\u03b5-dependent MARCKS phosphorylation in neonatal and adult rat ventricular myocytes","volume":"42","author":"Heidkamp","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib68","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/en.139.5.2579","article-title":"Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes","volume":"139","author":"Heymes","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib69","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00029.2005","article-title":"Nox2 -containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy","volume":"16","author":"Hingtgen","year":"2006","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib70","first-page":"84","article-title":"Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro","volume":"5","author":"Hirata","year":"1994","journal-title":"Blood Press Suppl"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib71","doi-asserted-by":"crossref","first-page":"C948","DOI":"10.1152\/ajpcell.1989.257.5.C948","article-title":"Hyperthyroid adult rat cardiomyocytes. I. Nucleotide content, \u03b2- and \u03b1-adrenoceptors, and cAMP production","volume":"257","author":"Hohl","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib72","first-page":"R1473","article-title":"Thyroxine-induced cardiac hypertrophy: Influence of adrenergic nervous system versus renin\u2013angiotensin system on myocyte remodeling","volume":"285","author":"Hu","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib73","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","article-title":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats","volume":"90","author":"Huentelman","year":"2005","journal-title":"Exp Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib74","doi-asserted-by":"crossref","first-page":"14266","DOI":"10.1074\/jbc.M107167200","article-title":"Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes","volume":"277","author":"Hunton","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib75","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1053\/jhep.2003.50369","article-title":"Left ventrciular hypertrophy in rats with biliary cirrhosis","volume":"39","author":"Inserte","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib76","doi-asserted-by":"crossref","first-page":"H666","DOI":"10.1152\/ajpheart.1993.265.2.H666","article-title":"Electrically stimulated contraction accelerates protein synthesis rates in adult feline cardiomyocytes","volume":"265","author":"Ivester","year":"1993","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib77","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI116579","article-title":"Endothelin-1 is an autocrine\/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes","volume":"92","author":"Ito","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib78","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.69.1.209","article-title":"Endothelin-1 induced hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes","volume":"69","author":"Ito","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib79","first-page":"H666","article-title":"Electrically stimulated contraction accelerates protein synthesis rates in adult feline cardiocytes","volume":"265","author":"Ivester","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib80","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-5793(92)80071-N","article-title":"Identification of two subtypes in the rat type 1 angiotensin II receptor","volume":"298","author":"Iwai","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pharmthera.2008.05.010_bib81","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.bbrc.2004.12.128","article-title":"PKC\u03b5-PKD1 signal complex at Z-discs plays a pivotal role in cardiac hypertrophy induced by G-protein coupled receptor agonists","volume":"327","author":"Iwata","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11010-005-3781-x","article-title":"Protein kinase C isozymes in hypertension and hypertrophy: Insight from SHHF rat hearts","volume":"270","author":"Johnsen","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib83","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.yjmcc.2004.08.004","article-title":"Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT2 receptor blockade","volume":"37","author":"Jones","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib84","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1006\/bbrc.1993.1962","article-title":"Up -regulation of ETB receptor mRNA by angiotensin in rat cardiomyocytes","volume":"194","author":"Kanno","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib85","doi-asserted-by":"crossref","first-page":"H1351","DOI":"10.1152\/ajpheart.01186.2004","article-title":"Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure","volume":"289","author":"Karram","year":"2005","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib86","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02619489","article-title":"Rat myocardial cells in vitro: Mitosis and differentiation properties","volume":"8","author":"Kasten","year":"1972","journal-title":"In vitro"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib87","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1113\/expphysiol.2004.028522","article-title":"Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension","volume":"90","author":"Katovich","year":"2005","journal-title":"Exp Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib88","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cardiores.2005.04.030","article-title":"Blockade of NF-\u03baB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II","volume":"67","author":"Kawano","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib89","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-2828(88)80122-6","article-title":"Beating rate, myosin subunits and CK-isozymes","volume":"20","author":"Kessler-Icekson","year":"1988","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib90","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.gt.3302670","article-title":"Dominant-negative c-jun inhibits rat cardiac hypetrophy induced by angiotensin II and hypertension","volume":"13","author":"Kim-Mitsuyama","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib91","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1074\/jbc.M511024200","article-title":"Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms","volume":"281","author":"Kim","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib92","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/endo-123-1-203","article-title":"Thyroxine-induced hypertrophy: Time course of development and inhibition by propanolol","volume":"123","author":"Klein","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib93","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.275.5303.1132","article-title":"The release of cyctochrome C from mitochondria: A primary site for Bcl-2 regulation of apoptosis","volume":"275","author":"Kluck","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib94","doi-asserted-by":"crossref","first-page":"24037","DOI":"10.1074\/jbc.273.37.24037","article-title":"Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice","volume":"273","author":"Kudoh","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib95","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11010-005-3085-1","article-title":"Increased expression of IL-6 and LIF in the hypertrophied left ventricle of TGR(mRen2)27 and SHR rats","volume":"269","author":"Kurdi","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib96","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.HYP.0000050101.90932.14","article-title":"Cardiac angiotensin II type 2 receptor activates the kinin\/NO system and inhibits fibrosis","volume":"41","author":"Kurisu","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib97","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1139\/Y05-146","article-title":"The interrelation of the angiotensin and endothelin systems on the modulation of NADPH oxidase","volume":"84","author":"Laplante","year":"2006","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib98","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cardiores.2006.07.006","article-title":"Antioxidant actions contribute to the antihypertrophic effects of atrial antriuretic peptide in neonatal rat cardiomyocytes","volume":"72","author":"Laskovski","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib99","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0008-6363(01)00540-5","article-title":"Impact of HMG CoA reductase inhibition on small GTPases in the heart","volume":"53","author":"Laufs","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00421-006-0161-5","article-title":"Effects of exercise training on pathological cardiac hypertrophy related gene expression and apoptosis","volume":"97","author":"Lee","year":"2006","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib101","doi-asserted-by":"crossref","first-page":"H1281","DOI":"10.1152\/ajpheart.00792.2005","article-title":"Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats","volume":"291","author":"Lee","year":"2006","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib102","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10557-005-0443-x","article-title":"Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type 2 receptor expression","volume":"19","author":"Li","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib103","first-page":"6267","article-title":"Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells","volume":"59","author":"Li","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib104","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/HYPERTENSIONAHA.106.085399","article-title":"Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice","volume":"49","author":"Li","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cardfail.2006.11.005","article-title":"Molecular signalling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure","volume":"13","author":"Li","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib106","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.freeradbiomed.2004.10.020","article-title":"Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signalling transduction pathways","volume":"38","author":"Li","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib107","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cardfail.2006.04.006","article-title":"p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats","volume":"12","author":"Liang","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib108","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00109-005-0718-5","article-title":"Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy","volume":"84","author":"Lieb","year":"2006","journal-title":"J Mol Med"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib109","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cardiores.2006.02.010","article-title":"Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: A possible role for SGK1","volume":"70","author":"Lister","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib110","first-page":"H279","article-title":"Role of myofibrillogenesis regulator-1 in myocardial hypertrophy","volume":"290","author":"Liu","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib111","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cardfail.2004.04.004","article-title":"Inhibition of p38 mitogen activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarction","volume":"11","author":"Liu","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib112","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.yjmcc.2006.03.433","article-title":"Differential hypertrophic effects of cardiotrophin-1 on adult cardiomyocytes from normotensive and spontaneously hypertensive rats","volume":"41","author":"Lopez","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib113","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjhyper.2005.05.013","article-title":"Role of aldosterone in left ventricular hypertrophy in hypertension","volume":"19","author":"Matsumura","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib114","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI1885","article-title":"Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects","volume":"101","author":"Masaki","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib115","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.mehy.2003.12.054","article-title":"Nutritional modulation of parathyroid hormone secretion may influence risk for left ventricular hypertrophy","volume":"64","author":"McCarty","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib116","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signalling: Physiological and pathophysiological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib117","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijcard.2005.09.003","article-title":"Angiotensin II activates apoptosis, proliferation and protein synthesis in the left ventricle of newborn albino rats","volume":"112","author":"Mel'nikova","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib118","first-page":"375","article-title":"Upregulation of angiotensin AT1a receptors mRNA in the heart and renal medulla after myocardial infarction in rats","volume":"57","author":"Milik","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib119","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0024-3205(03)00484-3","article-title":"Angiotensin I modulates gene expression of adrenomedullin receptor components in rat cardiomyocytes","volume":"73","author":"Mishima","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib120","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2337\/diabetes.54.2.394","article-title":"Hyperglycemia activates JAK2 signalling pathway in human failing myocytes via angiotensin II-mediated oxidative stress","volume":"54","author":"Moedsti","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib121","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2006.01.004","article-title":"Contractile effects of angiotensin and endothelin in failing and non-failing human hearts","volume":"114","author":"Mollmann","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib122","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.lfs.2006.04.005","article-title":"HMG-CoA reductase inhibitor fluvostatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1","volume":"79","author":"Morikawa-Futamatsu","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib123","doi-asserted-by":"crossref","unstructured":"Mufti, S., Wenzel, S., Euler, G., Piper, H.M., Schl\u00fcter, K.-D. (in press). Angiotensin II-dependent loss of cardiac function: mechanisms and pharmacological targets attenuating this effect. J Cell Physiol. doi:10.1002\/jcp.21501","DOI":"10.1002\/jcp.21501"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib124","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1291\/hypres.26.89","article-title":"Angiotensin II type 2 receptor blockade partially negates antihypertrophic effects of type 1 receptor blockade on pressure-overload rat cardiac hypertrophy","volume":"26","author":"Mukawa","year":"2003","journal-title":"Hypertension Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib125","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1253\/circj.71.1310","article-title":"Genetic disruption of angiotensin II type 1a receptor improves long-term survival of mice with chronic severe aortic regurgitation","volume":"71","author":"Nakanishi","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib126","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.HYP.0000173420.31354.ef","article-title":"Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically mice","volume":"46","author":"Nakanishi","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib127","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/0470029331.ch5","article-title":"Mechanisms of angiotensin II-dependent progression to heart failure","volume":"274","author":"Nemer","year":"2006","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib128","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/y05-068","article-title":"Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy","volume":"83","author":"Neves","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0006-291X(05)81376-2","article-title":"Inhibition of endothelin-1 induced myocardial protein synthesis by an antisense oligonucleotide against the early growth response gene-1","volume":"181","author":"Neyses","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.106.637124","article-title":"Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signalling","volume":"114","author":"Ni","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib131","doi-asserted-by":"crossref","first-page":"18434","DOI":"10.1074\/jbc.M409710200","article-title":"G\u03b112\/13- and reactive oxygen species-dependent activation of c-jun NH2-terminal kinase and p38 mitogen-activated proein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes","volume":"280","author":"Nishida","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib132","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib133","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.HYP.0000053447.64213.C4","article-title":"Ventricular adrenomedullin system in the transition from LVH to heart failure in rats","volume":"41","author":"Nishikimi","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib134","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/01.HYP.0000097604.64716.D2","article-title":"Chronic administration of adrenomedullin attenuates transition from left ventricular hypertrophy to heart failure in rats","volume":"42","author":"Nishikimi","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib135","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib136","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.yjmcc.2006.10.020","article-title":"Upregulation of TRPC1 in the development of cardiac hypertrophy","volume":"42","author":"Ohba","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib137","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/01.hjh.0000166851.18463.85","article-title":"Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: A LIFE study","volume":"23","author":"Olsen","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib138","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.peptides.2004.05.009","article-title":"Differential gene expression of adenomedullin receptors in pressure- and volume-overloaded heart \u2014 Role of angiotensin II","volume":"25","author":"Onitsuka","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib139","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-2005-861471","article-title":"Angiotensin II stimulates cardiac adrenomedullin production and causes accumulation of mature adrenomedullin independently of hemodynamic stress in vivo","volume":"37","author":"Onitsuka","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib140","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1038\/sj.emboj.7601417","article-title":"TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy","volume":"25","author":"Onohara","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib141","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.abb.2004.11.027","article-title":"Treatment with AT1 receptor blocker restores diabetes-induced alterations in intracellular Ca2+ transients and contractile function of rat myocyardium","volume":"435","author":"Ozdemir","year":"2005","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib142","doi-asserted-by":"crossref","first-page":"54905","DOI":"10.1074\/jbc.M407383200","article-title":"Mitogen-activated protein kinase and mitogen-activated protein kinase phosphatases mediate the inhibitory effects of all-trans retinoic acid on the hypertrophic growth of cardiomyocytes","volume":"279","author":"Palm-Leis","year":"2004","journal-title":"J Bol Chem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib143","first-page":"H96","article-title":"Angiotensin II -induced inotropy in rat ventricular myocytes: Role of reactive oxygen species and p38 MAPK","volume":"290","author":"Palomeque","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib144","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI13627","article-title":"Dilated cardiomyopathy and impaired cardiac hypertrophy response to angiotensin II in mice lacking FGF-2","volume":"108","author":"Pellieux","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib145","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1161\/CIRCULATIONAHA.104.528695","article-title":"Angiotensin-converting enzyme inhibitors: A new mechanism of action","volume":"112","author":"Peng","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib146","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib147","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s002100100469","article-title":"Noradrenaline-induced increase in protein synthesis in adult rat cardiomyocytes: Involvement of only \u03b11A-adrenoceptors","volume":"364","author":"P\u00f6nicke","year":"2001","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib148","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","article-title":"Activation of NF-\u03baB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes","volume":"98","author":"Purcell","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib149","first-page":"148","article-title":"Inhibitory effect of quercetin on cultured neonatal rat cardiomyocytes hypertrophy induced by angiotensin","volume":"22","author":"Qin","year":"2001","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib150","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1745-7254.2006.00370.x","article-title":"FAK-related nonkinase attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes","volume":"27","author":"Qin","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib151","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1139\/cjpp-74-2-125","article-title":"The angiotensin II subtype (AT2) receptor is linked to protein kinase C but not cAMP-dependent pathways in the cardiomyocytes","volume":"74","author":"Rabkin","year":"1996","journal-title":"Can J Physiol Pharamcol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib152","doi-asserted-by":"crossref","first-page":"16284","DOI":"10.1073\/pnas.0607583103","article-title":"Beta-arrestin2-mediated inotropic effects of angiotensin II type 1A receptor in isolated cardiac myocytes","volume":"103","author":"Rajagopal","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib154","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1096\/fj.02-0321fje","article-title":"AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NFAT pathway","volume":"17","author":"Ritter","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib155","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.HYP.0000176236.55322.18","article-title":"Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes","volume":"46","author":"Rude","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib156","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s004240100710","article-title":"Specific role for the extracellular signal -regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro","volume":"443","author":"Ruf","year":"2002","journal-title":"Pfl\u00fcgers Arch \u2013 Eur J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib157","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib158","doi-asserted-by":"crossref","first-page":"H787","DOI":"10.1152\/ajpheart.00974.2005","article-title":"Hyperinsulinemia: Effect on cardiac mass\/function, angiotensin II receptor expression, and insulin signalling pathways","volume":"291","author":"Samuelsson","year":"2006","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib159","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.HYP.0000215289.51180.5c","article-title":"Impairement of in vitro and in vivo heart function in angiotensin-(1\u20137) receptor mas knockout mice","volume":"47","author":"Santos","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib160","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1161\/CIRCULATIONAHA.106.657981","article-title":"Inhibition of apoptosis-regulated signalling kinase-1 and prevention of congestive heart failure by estrogen","volume":"115","author":"Satoh","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib161","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1073\/pnas.0510444103","article-title":"Requirement of Rac1 in the development of cardiac hypertrophy","volume":"103","author":"Satoh","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib162","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11010-006-9261-0","article-title":"Transient receptor potential (TRP) protein 7 acts as a G protein-activated Ca2+ channel mediating angiotensin II-induced myocardial apoptosis","volume":"294","author":"Satoh","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib163","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0735-1097(00)01065-2","article-title":"Beta-adrenoceptor stimulation attenuates the hypertrophic effect of alpha-adrenoceptor stimulation in adult rat ventricular cardiomyocytes","volume":"37","author":"Sch\u00e4fer","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib164","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0006-291X(86)90293-7","article-title":"Age-dependent changes in expression of \u03b11-adrenergic receptors in rat myocardium","volume":"138","author":"Schaffer","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib165","doi-asserted-by":"crossref","first-page":"C1347","DOI":"10.1152\/ajpcell.1995.269.6.C1347","article-title":"Regulation of protein synthesis and degradation in adult ventricular cardiomyocytes","volume":"269","author":"Schl\u00fcter","year":"1995","journal-title":"Am J Physiol (Cell Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib166","doi-asserted-by":"crossref","first-page":"H1739","DOI":"10.1152\/ajpheart.1992.263.6.H1739","article-title":"Trophic effects of catecholamines and parathyroid hormone on adult ventrciular cardiomyocytes","volume":"263","author":"Schl\u00fcter","year":"1992","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib167","first-page":"H1655","article-title":"Early response kinase and PI3-kinase activation in adult cardiomyocytes and their role in hypertrophy","volume":"276","author":"Schl\u00fcter","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib168","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/bj3100439","article-title":"Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phophodiesterase activity","volume":"310","author":"Schl\u00fcter","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib169","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cardiores.2004.06.012","article-title":"Synchronization and integration of multiple hypertrophic pathways in the heart","volume":"63","author":"Schl\u00fcter","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.cardiores.2004.04.032","article-title":"Inhibition of Ca2+-dependent PKC isoforms unmasks ERK-dependent hypertrophic growth evoked by phenylephrine in adult ventricular cardiomyocytes","volume":"63","author":"Schreckenberg","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib171","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00109-006-0090-0","article-title":"Angiotensin II stimulates apoptosis via TGF-\u03b21 signalling in ventricular cardiomyocytes of rat","volume":"84","author":"Schr\u00f6der","year":"2006","journal-title":"J Mol Med"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib172","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.76.3.489","article-title":"Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II","volume":"76","author":"Schunkert","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib173","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0022-2828(81)90327-8","article-title":"Isolation and development in cell culture of myocardial cells of the adult rat","volume":"13","author":"Schwartfeld","year":"1981","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib174","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000159245","article-title":"Subendothelial proteoglycan synthesis and transforming growth factor beta distribution correlate with susceptibility to atherosclerosis","volume":"34","author":"Scott","year":"1997","journal-title":"J Vasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib175","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1172\/JCI10037","article-title":"Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload","volume":"106","author":"Senbonmatsu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib176","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0006-2952(97)00653-9","article-title":"Ca2+ mobilization in adult rat cardiomyocytes by angiotensin type 1 and 2 receptors","volume":"55","author":"Shao","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib177","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/bbrc.2001.4744","article-title":"Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene expression via Ras\/Raf\/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes","volume":"283","author":"Shih","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib178","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1292\/jvms.68.271","article-title":"Cardiac remodeling and angiotensin II-forming enzyme activity of the left ventricle in hamsters with chronic pressure overload induced by ascending aortic stenosis","volume":"68","author":"Shimizu","year":"2006","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib179","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.RES.50.1.101","article-title":"Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells","volume":"50","author":"Simpson","year":"1982","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib180","first-page":"H939","article-title":"High-glucose-induced regulation of intracellular Ang II synthesis and nuclear redistribution in cardiac myocytes","volume":"293","author":"Singh","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib181","doi-asserted-by":"crossref","first-page":"20814","DOI":"10.1074\/jbc.M500528200","article-title":"The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signalling","volume":"280","author":"Skurk","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib182","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s00018-004-4244-3","article-title":"Hijacking epidermal growth factor receptors by angiotensin II: New possibilities for understanding and treating cardiac hypertrophy","volume":"61","author":"Smith","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib183","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0022-2828(89)90860-2","article-title":"Substrate oxidation by adult cardiomyocytes in long-term primary culture","volume":"21","author":"Spahr","year":"1989","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib184","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1073\/pnas.0408704102","article-title":"Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase","volume":"102","author":"Swaney","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib185","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.lfs.2004.12.048","article-title":"Continuous inhibition of the renin\u2013angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats","volume":"77","author":"Takemori","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib186","doi-asserted-by":"crossref","first-page":"H1560","DOI":"10.1152\/ajpheart.00941.2004","article-title":"Angiotensin-(1\u20137) inhibits growth of cardiac myocytes through activation of the mas receptor","volume":"289","author":"Tallant","year":"2005","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib187","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.febslet.2005.01.068","article-title":"The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy","volume":"579","author":"Tanaka","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib188","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/en.131.1.374","article-title":"Characterization of nuclear angiotensin II-binding sites in rat liver and comparison with plasma membrane receptors","volume":"131","author":"Tang","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib189","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/01.CIR.95.12.2677","article-title":"Load-induced growth responses in isolated adult rat hearts. Role of the AT1 receptor","volume":"95","author":"Thienelt","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib190","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/hmg\/ddh147","article-title":"Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats","volume":"13","author":"Tian","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib191","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/pr.59.1.2","article-title":"Interaction of endothelial nitric oxide and angiotensin in the circulation","volume":"59","author":"Toda","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib192","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.RES.0000079794.57578.F1","article-title":"Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to \u03b2-adrenergic receptor stimulation","volume":"93","author":"Tomita","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib193","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1590\/S0100-879X2002000900001","article-title":"Recent advances in angiotensin II signalling","volume":"35","author":"Touyz","year":"2002","journal-title":"Braz J Med Bio Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib194","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/01.HYP.0000158845.49943.5e","article-title":"Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp90phox-containing NADPH oxidase","volume":"45","author":"Touyz","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib195","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/01.HYP.27.5.1090","article-title":"Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors","volume":"27","author":"Touyz","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib196","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cardiores.2004.11.004","article-title":"Antifibrotic effect of adenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats","volume":"65","author":"Tsuruda","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib197","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.febslet.2005.11.044","article-title":"Differential \u03b2-arrestin binding of AT1 and AT2 angiotensin receptors","volume":"580","author":"Turu","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib198","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1006\/jmcc.2000.1135","article-title":"Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy","volume":"32","author":"Ueyama","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib199","first-page":"S95","article-title":"Angiotensin receptors","volume":"14","author":"Unger","year":"1996","journal-title":"J Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/dmrr.611","article-title":"The multi-faceted cross-talk between insulin and angiotensin II signalling systems","volume":"22","author":"Velloso","year":"2006","journal-title":"Diabetes Metabol Res Rev"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib201","first-page":"H1004","article-title":"Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling","volume":"290","author":"Voros","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib202","first-page":"481","article-title":"Chronic administration of angiotensin-(1\u20137) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats","volume":"25","author":"Wang","year":"2005","journal-title":"Di Yi Jub Yi Da Xue Xue Bao"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib203","doi-asserted-by":"crossref","first-page":"9829","DOI":"10.1128\/MCB.25.22.9829-9844.2005","article-title":"Convergence of protein kinase C and JAK-STAT signalling on transcription factor GATA-4","volume":"25","author":"Wang","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib204","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1139\/Y06-043","article-title":"Effects of triiodo-thyronine on angiotensin-induced cardiomyocytes hypertrophy: Reversal of increased \u03b2-myosin heavy chain gene expression","volume":"84","author":"Wang","year":"2006","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib205","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/01.CIR.95.6.1592","article-title":"Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis","volume":"95","author":"Weinberg","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib206","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejheart.2004.07.001","article-title":"p38 MAP-kinase in cultured adult rat ventricular cardiomyocytes: Expression and involvement in hypertrophic signalling","volume":"7","author":"Wenzel","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib207","series-title":"New Research on Signal Transduction\u201d","article-title":"Angiotensin II signalling in cardiomyocytes","author":"Wenzel","year":"2006"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib208","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1096\/fj.00-0827fje","article-title":"Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-\u03b2 expression in adult ventricular cardiomyocytes","volume":"15","author":"Wenzel","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib209","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/S0021-9258(17)40528-X","article-title":"Thyroid hormone regulation of \u03b2-adrenergic receptor number","volume":"252","author":"Williams","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib210","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.freeradbiomed.2005.12.009","article-title":"Metallotheinein alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of Ca2+ cycling proteins, NADPH oxidase, poly (ADP-ribosyl) polymerase and myosin heavy chain isozyme","volume":"40","author":"Wold","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib211","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.freeradbiomed.2005.08.006","article-title":"Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes","volume":"39","author":"Wu","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib212","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.HYP.0000205833.89478.5b","article-title":"Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II","volume":"47","author":"Yamamoto","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib213","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-0115(97)01033-1","article-title":"The AT4 receptor agonist [Nle1]-angiotensin IV reduces mechanically induced immediate-early gene expression in the isolated rabbit heart","volume":"71","author":"Yang","year":"1997","journal-title":"Reg Peptides"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib214","first-page":"116","article-title":"Simvastatin inhibits hypertension-induced cardiac hypertrophy in rats through activation of heme oxygenase-1\/carbon monoxide pathway","volume":"58","author":"Yao","year":"2006","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib215","first-page":"H912","article-title":"Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade","volume":"292","author":"Yaras","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib216","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejheart.2005.05.014","article-title":"Mechanical stretch-induced hypertrophy of neonatal rat ventricular myocytes is mediated by \u03b2(1)-integrin-microtubule signalling pathways","volume":"8","author":"Yutao","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib217","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.RES.0000240147.49390.61","article-title":"An angiotensin II type 1 receptor mutant lacking epidermal growth factor transactivation does not induce angiotensin II-mediated cardiac hypertrophy","volume":"99","author":"Zhai","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib218","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0008-6363(02)00610-7","article-title":"Protein kinase \u03b2II activation induces angiotensin converting enzyme expression in neonatal rat cardiomyocytes","volume":"57","author":"Zhang","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib219","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/01.HYP.27.2.269","article-title":"Protein kinase C modulation of cardiomyocyte angiotensin II and vasopressin receptor desensitization","volume":"27","author":"Zhang","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib220","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.yjmcc.2005.02.009","article-title":"A major role for AT1b receptor in mouse mesenteric resistance vessels and its distribution in heart and neuroendocrine tissues","volume":"38","author":"Zhou","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib221","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbrc.2005.11.060","article-title":"Thrombospondin 1 mediates angiotensin II induction of TGF-\u03b2 activation by cardiac and renal cells under both high and low glucose conditions","volume":"339","author":"Zhou","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib222","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejphar.2007.03.047","article-title":"17\u03b2-estradiol inhibits angiotensin II-induced collagen synthesis of cultured rat cardiac fibroblasts via modulating angiotensin II receptors","volume":"567","author":"Zhou","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib223","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3317\/jraas.2000.039","article-title":"Effects of losartan on haemodynamic parameter and angiotensin receptor mRNA levels in rat heart after myocardial infarction","volume":"1","author":"Zhu","year":"2000","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib224","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.lfs.2006.02.041","article-title":"Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats","volume":"79","author":"Ziegelhofer-Mihalovicova","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.05.010_bib225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0735-1097(02)02624-4","article-title":"Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure?","volume":"41","author":"Zittermann","year":"2003","journal-title":"J Am Coll Cardiol"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725808001071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725808001071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T12:42:03Z","timestamp":1631450523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725808001071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":225,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0163725808001071"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2008.05.010","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}